Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

WASHINGTON — President Donald Trump’s top allies are pushing for Congress to fund a costly White House ballroom after the president was evacuated from a dinner Saturday in a sprawling hotel ballroom ...

For a year and a half, Yves Valerus was working a stable, full time job with a regular weekly schedule, a set hourly rate and benefits. The Haitian Creole-English interpreter helps people bridge ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...